The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Short-Term Efficacy of Methylphenidate: A Randomized, Double-Blind, Placebo-Controlled Trial Among Survivors of Childhood Cancer
Abstract
Purpose: Children surviving acute lymphoblastic leukemia (ALL) and malignant brain tumors (BTs) have a higher incidence of attention and learning problems in school than do their healthy peers. The present study tests the hypothesis that the psychostimulant methylphenidate (MPH) improves cognitive and social functioning among these patients. Patients and Methods: We report on 83 long-term survivors of ALL and BT identified as having attentional deficits on behavioral testing and parent or teacher report, and problems with academic achievement. The 47 male and 36 female patients ranged from 0.6 to 14.3 years (median, 5.4 years) of age at diagnosis and 6.7 to 17.9 years (median, 11.9 years) of age at participation. The patients (40 ALL, 43 BT) participated in a randomized, double-blind, 3-week home cross-over trial of placebo (bid), low-dose MPH (0.3 mg/kg; maximum dose, 10 mg bid), and moderate-dose MPH (0.6 mg/kg; maximum dose, 20 mg bid). The primary end points were weekly teacher and parent reports on the Conners’ Rating Scales and Social Skills Rating System. Results: Compared to placebo, significant improvement with MPH was reported by teachers and parents on the Conners’ Rating Scales and by teachers on the Social Skills Rating System. However, no consistent advantage of moderate dose over low dose was observed. Of those participating, 66 (79.5%) of the 83 patients continued on best clinical management. Conclusion: Treatment with MPH can at least temporarily reduce some attentional and social deficits among survivors of childhood ALL and BT. Long-term follow-up will reveal those subsets of patients who are more likely to benefit from MPH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Castellanos, F. X. (2002) · JAMA · doi:10.1001/jama.288.14.1740 · Cited by 1,646
Biederman, J., Faraone, S. V., Monuteaux, M. C., Plunkett, E. A., Gifford, J., & Spencer, T. (2003) · Pediatrics · doi:10.1542/peds.111.5.1010 · Cited by 133
Cited by
Neurocognitive Consequences of Risk-Adapted Therapy for Childhood Medulloblastoma
Mulhern, R. K., Palmer, S. L., Merchant, T. E., Wallace, D., Kocak, M., Brouwers, P., Krull, K., Chintagumpala, M., Stargatt, R., Ashley, D. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.703 · Cited by 402
Self-citationButler, J. M., Case, L. D., Atkins, J., Frizzell, B., Sanders, G., Griffin, P., Lesser, G., McMullen, K., McQuellon, R., Naughton, M., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.05.076 · Cited by 214
Neurocognitive effects of treatment for childhood cancer
Butler, R. W., & Haser, J. K. (2006) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20110 · Cited by 203
Michel, G., Brinkman, T. M., Wakefield, C. E., & Grootenhuis, M. (2020) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2020.07.005 · Cited by 133
Reddick, W. E., Taghipour, D. J., Glass, J. O., Ashford, J., Xiong, X., Wu, S., Bonner, M., Khan, R. B., & Conklin, H. M. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.24947 · Cited by 121
Self-citation
Metadata
- Authors
- Mulhern, R. K., Khan, R. B., Kaplan, S., Helton, S., Christensen, R., Bonner, M., Brown, R., Xiong, X., Wu, S., Gururangan, S., & Reddick, W. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-12-01
- Volume
- 22
- Issue
- 23
- Pages
- 4795-4803
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2148425638
- Cited by
- 190
- References
- 2
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Short-Term Efficacy of Methylphenidate: A Randomized, Double-Blind, Placebo-Controlled Trial Among Survivors of Childhood Cancer. https://app.cochat.ai/papers/10.1200/jco.2004.04.128
- The paper
- Mulhern, R. K., Khan, R. B., Kaplan, S., Helton, S., Christensen, R., Bonner, M., Brown, R., Xiong, X., Wu, S., Gururangan, S., & Reddick, W. E. (2004). Short-Term Efficacy of Methylphenidate: A Randomized, Double-Blind, Placebo-Controlled Trial Among Survivors of Childhood Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2004.04.128
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.